Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer.
about
Chemotherapy-induced neuropathies-a growing problem for patients and health care providersIxabepilone for the treatment of endometrial cancer.Chemotherapy reaction induced by ixabepilone, a microtubule stabilizing agent, mimicking extramammary Paget's disease in a patient with breast carcinoma.Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.
P2860
Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer.
@en
type
label
Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer.
@en
prefLabel
Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer.
@en
P2093
P2860
P50
P1476
Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer
@en
P2093
Amelia D'Alessio
Maria Pergameno
Maria Sofia Piccirilli
Monica Rosaria Maiello
Nicoletta Chicchinelli
P2860
P304
P356
10.1517/17425255.2015.1057497
P407
P577
2015-07-01T00:00:00Z